Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more

Description

List of Tables

The global hyaluronic acid (HA) viscosupplementation market was valued at $2.5 billion in 2024 and is projected to grow at a CAGR of 2.9%, reaching $3 billion by 2031.

This market includes four primary product categories:

Single Injection
Two Injections
Three Injections
Five Injections

Market Insights & Data Coverage

Unit Sales & Average Selling Prices
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data (2021-2023)
Competitive Landscape, Mergers & Acquisitions
Company Profiles & Product Portfolios

Market Trends

Impact of COVID-19 on Market Growth:

* The COVID-19 pandemic led to a temporary decline in sales due to postponements of elective procedures.

* By 2022, the market rebounded, returning to steady growth.

Growing Prevalence of Osteoarthritis:

* Increased aging population and rising osteoarthritis cases are fueling demand for HA viscosupplementation.

Shift Towards Single-Injection Therapies:

* Convenience and lower patient burden are driving single-injection adoption.

Market Share Insights

Top Competitors in the Global Hyaluronic Acid Viscosupplementation Market (2024):

1 DePuy Synthes

* Market leader with its MONOVISC(R) (single-injection) and ORTHOVISC(R) (three-injection) products.

2 Fidia

* Second-largest market share with its HYMOVIS(R) (two-injection therapy).

3 Sanofi

* Third-largest competitor, offering Synvisc(R) and Synvisc-One(R), benefiting from the growing osteoarthritis market.

Market Segmentation Summary

Hyaluronic Acid Viscosupplementation Market

Single Injection Market
Two Injections Market
Three Injections Market
Five Injections Market

Global Research Scope

Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023

Quantitative Coverage

Market Size, Market Shares
Market Forecasts, Growth Rates
Units Sold, Average Selling Prices
Procedure Numbers

Qualitative Coverage

COVID-19 Impact
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls, Disruptive Technologies
Disease Overviews

Data Sources:

Primary Interviews with Industry Leaders
Government Physician Data & Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database

Product Code: iDATA_GLOB25_MC_HAV

TABLE OF CONTENT

7.1 Executive Summary
- 7.1.2 Competitive Analysis
- 7.1.3 Regions Included
7.2 Introduction
- 7.2.1 Benefits of Viscosupplementation
- 7.2.2 Synovial Fluid
- 7.2.3 Product Types
  - 7.2.3.1 Single-Injection Products
  - 7.2.3.2 Two-Injection Cycle Products
  - 7.2.3.3 Three-Injection Cycle Products
  - 7.2.3.4 Three-/Five-Injection Cycle Products
7.3 Procedure Numbers
7.4 Market Overview
- 7.4.1 By Segment
- 7.4.2 By Region
7.5 Market Analysis and Forecast
- 7.5.1 Total Hyaluronic Acid Viscosupplementation Market
- 7.5.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
- 7.5.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
- 7.5.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
- 7.5.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
7.6 Drivers and Limiters
- 7.6.1 Market Drivers
- 7.6.2 Market Limiters
7.7 Competitive Market Share Analysis